Clinical trial
Effects of Pioglitazone in Congenital Adrenal Hyperplasia
NCT00151710 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00151710 |
|---|---|
| Title | Effects of Pioglitazone in Congenital Adrenal Hyperplasia |
| Official title | Effects of Pioglitazone in Glucocorticoid-Induced Insulin Resistance. Studies in Congenital Adrenal Hyperplasia. |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Congenital Adrenal Hyperplasia |
| Intervention type | Drug |
| Interventions | Pioglitazone |
| First posted | Sep 9, 2005 |
| Last update posted | Mar 1, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: